Summary of Study ST000864
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000575. The data can be accessed directly via it's Project DOI: 10.21228/M8BM2Z This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
| Study ID | ST000864 |
| Study Title | Targeting Myelin Ceramides in PAR1 and PAR2 Mice after SCI |
| Study Summary | Targeting Myelin ceramides in PAR1 and PAR2 Mice after SCI. The samples submitted are purified myelin preparations from the postnatal day 21 or 60 mouse spinal cord (SC). There are 30 total sampes, n=5 for each group. wild type control, PAR1 KO and PAR2 KO at P21 and P60 days. |
| Institute | Mayo Clinic |
| Last Name | Scarisbrick |
| First Name | Isobel |
| Address | 200 First Street SW, Rochester, MN 55905 |
| scarisbrick.isobel@mayo.edu | |
| Phone | 507-284-0124 |
| Submit Date | 2017-08-10 |
| Analysis Type Detail | LC-MS |
| Release Date | 2021-02-17 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Combined analysis:
| Analysis ID | AN001389 |
|---|---|
| Analysis type | MS |
| Chromatography type | Reversed phase |
| Chromatography system | Waters Acquity |
| Column | Waters Acquity BEH C8 (150 x 2mm,1.7um) |
| MS Type | ESI |
| MS instrument type | Triple quadrupole |
| MS instrument name | Thermo Quantum Ultra |
| Ion Mode | POSITIVE |
| Units | units = ng/vial |
Chromatography:
| Chromatography ID: | CH000973 |
| Instrument Name: | Waters Acquity |
| Column Name: | Waters Acquity BEH C8 (150 x 2mm,1.7um) |
| Chromatography Type: | Reversed phase |
